Recce Pharmaceuticals (ASX:RCE) gains ethics approval to expand phase I/II trial of R327
Recce Pharmaceuticals (ASX:RCE) has obtained approval from the Human Research Ethics Committee to expand its trial…
| Change | ||
| S&P/ASX Sm. Ords. | |||
| All Ordinaries | |||
| S&P/ASX 100 |